-
LG Chem Life Sciences Expands Partnership with Avacta Group plc
Nov 13, 2019, 10:32 AM by Michael CroftCAMBRIDGE, UK, UNITED KINGDOM - Nov 13, 2019 - Avacta Group plc (AIM:AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to provide an update on the Affimer therapeutics development partnership and license agreement with LG Chem Life Sciences (LG Chem), part of the South Korean LG Group, to develop Affimer therapeutics in several disease areasFull story -
Turbine secures €3 million EUR seed fund to expand the potential of simulation-first drug discovery
Nov 13, 2019, 10:30 AM by Michael CroftLONDON, UK & BUDAPEST, HUNGARY - Nov 13, 2019 - Turbine, a simulation-based drug discovery company today announced the closing of an institutional financing round led by Delin VenturesFull story -
Tumor Organoids For High-Throughput Drug Screening
Nov 13, 2019, 07:20 AM by Michael CroftFull storyBio-IT World | Interest is growing among oncology researchers in using tumor organoids to mimic cancer characteristics and drug responses in humans.
-
X4 Pharmaceuticals Receives Breakthrough Therapy Designation from the FDA for Mavorixafor for the Treatment of WHIM Syndrome
Nov 12, 2019, 09:35 AM by Michael CroftCAMBRIDGE, MA, UNITED STATES - Nov 12, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced that the UFull story -
Lifebit Announces General Release of its Federated Genomics Cloud Operating System
Nov 8, 2019, 10:53 AM by Michael CroftLONDON, UK - Nov 7, 2019 - Lifebit Biotech, a leading innovator in bioinformatics and cognitive software solutions, announced today the general release of Lifebit CloudOSFull story -
OptraHEALTH, InformedDNA Partner To Expand Access To Genetics Experts
Nov 8, 2019, 09:20 AM by Michael CroftFull storyBio-IT World News Brief | OptraHEALTH and InformedDNA today announced that they will partner to offer access to InformedDNA’s board-certified genetic counselors through GeneFAX’s AI-enabled CounselorConnect platform.
-
UKI2S wins Best Sector Support Organisation at the OBN Awards
Nov 8, 2019, 05:51 AM by Michael CroftLONDON, UK - Nov 8, 2019 - UK Innovation & Science Seed Fund (UKI2S) is delighted to announce it is has been awarded Best Sector Support Organisation at the 11th Annual OBN Awards celebration last nightFull story -
Signant Health Host 8th Annual eCOA Forum To Convene Clinical Operations and Outcomes Research Leaders Guiding the Future of Patient-Centric Technology
Nov 7, 2019, 11:42 AM by Michael CroftPHILADELPHIA, PA - Nov 7, 2019 - Signant Health is proud to host its 8th annual eCOA Forum, which convenes clinical operations and outcomes research leaders for the industry’s premier event focused on eCOA, eConsent, and patient-centric technologyFull story -
Signant Health Proud to Sponsor the Philadelphia Walk to End Alzheimer’s in Nationwide Effort to Build Awareness, Raise Funds and Advance Research Towards a Cure.
Nov 7, 2019, 09:04 AM by Michael CroftPHILADELPHIA, PA - Nov 7, 2019 - Signant Health, formerly CRF Health and Bracket, announced today that it is sponsoring the Philadelphia Walk to End AlzheimersFull story -
Healthy Gut Microbiome Reference Database Initiated
Nov 6, 2019, 06:30 AM by Michael CroftFull storyBio-IT World | A group of researchers describe an initial baseline healthy gut microbiome reference database and put forth a prototype reporting template. The goal behind the work is to map the healthy gut microbiome so that they and other researchers can use the data to develop disease-specific prediction models.
-
X4 Pharmaceuticals Initiates Phase 1b Clinical Trial of Mavorixafor for the Treatment of Severe Congenital Neutropenia
Nov 5, 2019, 10:16 AM by Michael CroftCAMBRIDGE, MA, UNITED STATES - Nov 5, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced the initiation of a Phase 1b clinical trial of mavorixafor (X4P-001) for the treatment of Severe Congenital Neutropenia (SCN), a group of rare blood disorders characterized by abnormally low levels of neutrophilsFull story -
Microway Showcases NVIDIA® DGX-2™ AI System at GTC DC 2019
Nov 4, 2019, 13:12 PM by Michael CroftPLYMOUTH, MA, UNITED STATES - Nov 4, 2019 - Microway, a leading provider of computational clusters, servers, and workstations for HPC and AI, announces the NVIDIA® DGX-2 system will be showcased in Microways booth at the GPU Technology Conference 2019, November 4th – 6th in Washington, DFull story -
LetsGetChecked Appoints Leading Healthcare Innovator Sasha Khursheed Said as Senior Vice President of Revenue
Nov 4, 2019, 12:48 PM by Michael CroftNEW YORK, NY, UNITED STATES - Nov 5, 2019 - New York - LetsGetChecked, a leading direct-to-consumer at-home health testing company, today announced the appointment of Sasha Khursheed Said as Senior Vice President of RevenueFull story -
BetterPT and PromptEMR Partner to Provide Industry-First, End-to-End Management Solution for Physical Therapy Practices
Nov 4, 2019, 12:18 PM by Michael CroftNEW YORK, NY, UNITED STATES - Oct 29, 2019 - New York – October 29, 2019 - BetterPT, an integrated healthcare technology platform company providing end-to-end digital connectivity between physical therapists (PT), patients, and physicians, and PromptEMR, a fully integrated enterprise solution to manage outpatient PT clinics, today announced a partnership to launch a first of its kind, turnkey business management system for PT clinicsFull story -
LetsGetChecked Appoints Healthcare Industry Veteran Troy Cox to Board of Directors
Nov 4, 2019, 11:59 AM by Michael CroftNEW YORK, NY, UNITED STATES - Nov 4, 2019 - New York- LetsGetChecked, a leading direct-to-consumer at-home health testing company, today announced the appointment of Troy Cox to its Board of DirectorsFull story -
X4 Pharmaceuticals Appoints Derek Meisner, J.D., as General Counsel
Nov 4, 2019, 09:34 AM by Michael CroftCAMBRIDGE, MA, UNITED STATES - Nov 4, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced the appointment of Derek Meisner, JFull story -
Shimmer Receives CE Certification for its ECGmd Holter Monitor Electrocardiograph
Nov 4, 2019, 08:04 AM by Michael CroftCAMBRIDGE, MA - Nov 4, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced that ECGmd – its five-wire, four-lead holter monitor electrocardiograph (ECG) – is now a CE certified, Class IIa medical device under the Medical Device Directive (93/42/EEC)Full story -
Microsoft + The Jackson Laboratory Using AI To Fight Cancer
Oct 31, 2019, 13:06 PM by Michael CroftThe AI Blog | Jackson Lab is using AI from Project Hanover to find the most relevant cancer-related info from the thousands of research papers published each day.Full story -
PetaGene, AstraZeneca, QIAGEN, and More: News From October 2019
Oct 31, 2019, 10:50 AM by Michael CroftFull storyBio-IT World | October featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including PetaGene, AstraZeneca, QIAGEN, and more.
-
Watson-Marlow Fluid Technology Group’s puresu single-use tube assemblies offer reliable, sterile, customisable solutions for bioprocessing
Oct 31, 2019, 06:24 AM by Michael CroftFALMOUTH, UK - Oct 31, 2019 - Watson-Marlow Fluid Technology Group (WMFTG) announces the expansion of its puresu® single-use range, providing a combination of components that are safe and easy-to-installFull story